News from Bioethics.com

Two Patients Show the Promise of a Historic Treatment, with an Equally Historic Price Tag

3 months 2 weeks

(CNBC) – The outcomes for Kaitlyn and Justin are part of the mysteries of medicine: why a cutting-edge therapy works for years for one person, and just months for another. Notably, this situation has been worked into Kymriah’s pricing. If the treatment is controlling patients’ cancer after a month, its price tag is $475,000. “The CAR-T therapy is administered to all patients who need it,” Novartis’ Bradner explained. “If the medicine is working at a fixed period of time, then Novartis is compensated. And if it doesn’t, then we feel good at having provided this chance for that patient.”

Students Look to Vending Machines for Better Access to Morning-After Pill

3 months 2 weeks

(New York Times) – It has been four years since the federal government lifted the age limit for the morning-after pill, but college students across the country say gaining access to it remains fraught with confusion and difficulty. Now some colleges think they have found a solution: vending machines stocked with the morning-after pill. Stanford University unveiled one this month, following in the footsteps of several other colleges, including the University of California, Santa Barbara and the University of California, Davis, which made headlines after it installed a “wellness” machine this year that sells the generic version of Plan B, as well as pregnancy tests, feminine hygiene products, Advil, Claritin and other items.

Pages

Creative Commons License